�㽶��Ƶ

John A. Moran Eye Center scientist Frans Vinberg, PhD, is part of a project bringing together more than 40 scientists, doctors, and industry experts hand-picked from around the country.

The John A. Moran Eye Center �㽶��Ƶ of Utah optical shop location will offer a 30% discount on all in-stock eyeglass frames and lenses on Wednesday, December 4.

A new robotic eye surgery device developed by Moran’s Paul S. Bernstein, MD, PhD, and the �㽶��Ƶ of Utah Magnetic & Medical Robotics Laboratory aims to transform retinal surgery by...

John A. Moran Eye Center physicians will teach ophthalmic skills, share research, and present on a wide variety of topics at the 2024 American Academy of Ophthalmology (AAO) annual meeting...

Choose from hundreds of designer styles from the world’s top eyewear brands, with representatives on hand to show off their latest designs. Bring your up-to-date eyeglasses prescription or schedule an...

Ian Pitha, MD, PhD, provides medical and surgical management of glaucoma, cataract surgery, and comprehensive ophthalmology care.

The John A. Moran Eye Center recently welcomed comprehensive optometrist Katherine Anderson, OD, to the team at our Parkway, Stansbury, Westridge, and Redwood Health Center locations.

The �㽶��Ƶ of Utah’s elite H.A. and Edna Benning Medical Society has selected renowned John A. Moran Eye Center researcher Liliana Werner, MD, PhD, for membership as the recipient of...

A new analysis of research conducted at the John A. Moran Eye Center supports further testing to determine if cataracts might someday be reversed with eye drops.

Doximity’s 2024-2025 Residency Navigator has ranked the John A. Moran Eye Center's residency program No. 6 nationwide and No. 1 in the West.

U.S. News & World Report has ranked the John A. Moran Eye Center at the �㽶��Ƶ of Utah among the nation’s Top 10 eye centers for a third year running.

A group of Utahns with vision loss recently visited the museum for a “touch tour” organized by the John A. Moran Eye Center’s Patient Support Program. The tour gave them...

Three new dry eye treatments are among the options available at the John A. Moran Eye Center for this complex condition that affects millions.

Through the Operation Sight program, Moran Eye Center doctors identify local patients for charitable surgery each month as they partner with organizations that hold free clinics.

A Moran Eye Center age-related macular degeneration (AMD) patient recently became the first in Utah to test a new gene therapy developed by the Sharon Eccles Steele Center for Translational...

Move over rose-colored glasses: millions of people with migraine have a new eyewear option as spring light and weather changes can increase attacks.

An audience of low-vision guests and their human and guide dog companions recently attended Utah Opera’s annual Blind and Visually Impaired Night in May, which featured a full-dress rehearsal of...

Oculoplastic surgeon Robert Kersten, MD, FACS, FASOPRS, directs an American Society of Oculofacial Plastic Surgery (ASOPRS)-approved fellowship, while retinal specialist Steffen Schmitz-Valckenberg, MD, oversees the new medical retina fellowship.

Visit the John A. Moran Eye Center at its �㽶��Ƶ of Utah (May 30) and Park City (May 31) locations and choose from hundreds of styles from the world's top...

The Achievement Rewards for College Scientists (ARCS) Foundation of Utah is supporting two incoming Moran Eye Center residents with research scholarships for 2024-2025.

More than 50 Utahns who are former refugees received comprehensive eye exams, eyeglasses, and charitable surgery referrals at the John A. Moran Eye Center’s Hope in Sight Outreach Clinic on...

Iqbal "Ike" K. Ahmed, MD, FRCSC, director of the Moran Eye Center’s Alan S. Crandall Center for Glaucoma Innovation, ranked No. 1 on the annual Power List of the 100...

The �㽶��Ƶ of Utah has awarded renowned age-related macular degeneration (AMD) researcher Gregory S. Hageman, PhD, the rank of distinguished professor.

Publishing in the prestigious journal Nature Communications, Moran's latest AMD research points the field away from a liver-produced protein others had identified as a promising therapeutic target.